Topical pharmacotherapies offer the unique advantage that the products are applied directly to the diseased skin, resulting in local, distinctly direct contact between the product and the affected skin. The choice of vehicle depends on the type of dermatosis. Vehicle polarity and vehicle viscosity result in optimal contact between the vehicle and affected skin, allowing uncomplicated application and distribution of the product.
Autoren
- Prof. Dr. phil. nat. Christian Surber
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Participation of the patient
Adherence in psychiatry
- AI in neurology
Control instead of a flood of data: AI makes big data and wearables usable
- Eosinophilic esophagitis
EoE rarely occurs in isolation
- Lung cancer with EGFR mutation
New perspectives in first-line therapy
- Sleep disorder
Sleep medicine in transition: new goals and a reassessment of old hypnotics
- Ginkgo biloba extract in the Alzheimer's mouse model
Effects on disease-associated microglia subpopulations
- "Patients W.A.I.T Indicator"
Access to medicines – how does Switzerland compare across Europe?
- Osteoporosis